Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 13 articles:
HTML format

Single Articles

    May 2020
    Interferon beta-1b for COVID-19.
    Lancet. 2020 May 8. pii: S0140-6736(20)31101.

    April 2019
    Alemtuzumab to be restricted pending review, says EMA.
    Lancet. 2019;393:1683.

    March 2018
  3. METZ LM, Liu WQ
    Effective treatment of progressive MS remains elusive.
    Lancet. 2018;391:1239-1240.

  4. KAPPOS L, Bar-Or A, Cree BAC, Fox RJ, et al
    Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30475.
    PubMed     Abstract available

  5. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Abstract available

    End of the road for daclizumab in multiple sclerosis.
    Lancet. 2018;391:1000.

    October 2017
  7. GREEN AJ, Gelfand JM, Cree BA, Bevan C, et al
    Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32346.
    PubMed     Abstract available

    March 2017
  8. ATKINS H, Freedman MS
    Immunoablation and aHSCT for aggressive multiple sclerosis - Authors' reply.
    Lancet. 2017;389:908.

  9. HARRIS M, Cossburn M, Gregory R
    Immunoablation and aHSCT for aggressive multiple sclerosis.
    Lancet. 2017;389:907-908.

    January 2017
  10. CHEN H, Kwong JC, Copes R, Tu K, et al
    Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
    Lancet. 2017 Jan 4. pii: S0140-6736(16)32399.
    PubMed     Abstract available

    November 2016
  11. COMI G, Radaelli M, Soelberg Sorensen P
    Evolving concepts in the treatment of relapsing multiple sclerosis.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)32388.
    PubMed     Abstract available

  12. ONTANEDA D, Thompson AJ, Fox RJ, Cohen JA, et al
    Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)31320.
    PubMed     Abstract available

  13. BROWNLEE WJ, Hardy TA, Fazekas F, Miller DH, et al
    Diagnosis of multiple sclerosis: progress and challenges.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)30959.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.